在多巴胺受体信号传递的角度看PKC
1School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.
Acta biochimica Polonica
|June 24, 2025
概括
蛋白激酶C (PKC) 对于细胞信号传递至关重要,并调节多巴胺受体功能. PKC的失调与帕金森氏症等神经系统疾病有关.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 蛋白激酶C (PKC) 是一个关键酶,参与细胞内信号转导.
- PKC调节关键的细胞过程,包括新陈代谢,生长,增殖和分化.
- PKC在多巴胺受体信号通路中发挥着重要作用.
研究的目的:
- 审查PKC在多巴胺受体信号转导中的作用.
- 阐明PKC在细胞内信号网络中的核心作用.
- 提供对多巴胺作用性疾病潜在治疗点的见解.
主要方法:
- 文献综述侧重于多巴胺受体和PKC之间的信号转导.
- 分析PKC参与多巴胺受体调节的生理功能.
- 检查PKC在神经疾病发病过程中的作用.
主要成果:
- PKC是细胞内信号传导网络中的一个关键枢纽.
- PKC通过多巴胺受体信号调节许多生理功能,包括多巴胺释放和受体下调.
- 异常PKC活动与精神分裂症,帕金森病和阿尔茨海默病等神经系统疾病有关.
结论:
- PKC是多巴胺受体信号传递和细胞功能的关键调节者.
- 了解PKC-多巴胺受体相互作用对于开发用于多巴胺作用疾病的治疗策略至关重要.
- 对PKC信号通路的进一步研究可能会揭示神经系统疾病治疗的新目标.
相关概念视频
GPCR Desensitization
6.6K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.6K
Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391
Amplifying Signals via Enzymatic Cascade
9.7K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
9.7K
Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
GPCRs Regulate Adenylyl Cylase Activity
6.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.0K
Opioid Receptors: Overview
2.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.0K


